All In Biotech

Free tool

FAERS Monitor: Celexa

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020822 or its brand name (Celexa, Citalopram Hydrobromide). Reports on generic versions are filed under their own applications.

Reports

114,378

Serious

86,497

76% of reports

Hospitalization

38,084

Death reported

15,414

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fatigue7,613
  • nausea7,137
  • drug ineffective6,331
  • diarrhoea5,443
  • headache5,402
  • dizziness4,850
  • pain4,821
  • fall4,768
  • anxiety4,682
  • dyspnoea4,671
  • toxicity to various agents4,505
  • off label use4,449
  • depression4,396
  • vomiting4,280
  • malaise3,653

Reports by year received

View as table
YearReports
20041,488
20051,270
20061,099
20071,009
2008964
20091,680
20102,609
20113,343
20124,660
20136,242
20147,587
20159,711
20169,757
20178,509
20189,026
20199,163
20207,577
20216,260
20225,139
20235,111
20244,489
20254,713
20262,966

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,939,781 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
toxicity to various agentsSignal4,5055.04.914,224
depressionSignal4,3963.63.58,194
anxietySignal4,6823.13.06,468
fallSignal4,7682.72.64,938
fatigue7,6131.81.82,815
dizziness4,8501.81.71,734
vomiting4,2801.71.61,194
nausea7,1371.71.61,948
headache5,4021.61.51,206
diarrhoea5,4431.61.51,103
malaise3,6531.51.5692
dyspnoea4,6711.51.5851
pain4,8211.41.4679
off label use4,4490.90.921
drug ineffective6,3310.90.9104

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.